Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Private equity group CVC shares soar on Amsterdam debut

Published 04/26/2024, 02:17 AM
Updated 04/26/2024, 09:15 AM
© Reuters. FILE PHOTO: Overview of Amsterdam's stock exchange interior as Prosus begins trading on the Euronext stock exchange in Amsterdam, Netherlands, September 11, 2019. REUTERS/Piroschka van de Wouw/File Photo

By Emma-Victoria Farr

AMSTERDAM (Reuters) -Shares of private equity group CVC Capital Partners gained as much as 25% on their first day of trading in Amsterdam in what shapes up to be one of Europe's largest initial public offerings this year.

CVC shares opened at 17.34 euros ($18.61) after they were priced earlier on Friday at 14 euros - the midpoint of the announced range - which valued one of Europe's largest buyout firms at around 14 billion euros.

Shares were trading at 17.18 euros by 1300 GMT after rising as high as 17.55 euros per share shortly after opening.

The company said it would raise 2-2.3 billion euros from the deal, depending on whether over-allotment options were exercised. CVC said the offer was oversubscribed multiple times and had been increased to accommodate strong demand from institutional investors globally.

"We are very pleased to have received great support for our IPO from both our new and existing shareholders," chief executive Rob Lucas said in a statement. "This is testament to the huge amount of hard work that has gone into building CVC over the last 40 years."

Investor demand came from mutual funds, sovereign wealth funds, hedge funds and big insurer pension funds split across Europe, the US and the Middle East, a person familiar with the process told Reuters.

The IPO is set to earn millions for some of the company's founders, while also helping CVC grow its assets beyond its 186 billion euros under management.

CVC had been considering an IPO for some time but abandoned a previous attempt due to volatile market conditions.

Europe has seen a string of companies go public recently, taking advantage of higher stock prices and improving investor sentiment.

However, new issue performance has been mixed. Last month shares in skin care company Galderma soared on its market debut, while CVC-backed cosmetics retailer Douglas did less well trading below its issue price.

CVC founders Donald Mackenzie and Steve Koltes stand to reap substantial rewards from the IPO. Based on the issue price and without exercising the over allotment option, Mackenzie is due to cash in around 121.7 million euros through the sale of existing shares, Reuters calculations based on the issue prospectus suggest. Koltes could raise around 27.7 million euros.

The IPO was led by investment banks Goldman Sachs, JP Morgan, and Morgan Stanley.

CVC is the latest European buyout group to go public, following in the footsteps of Bridgepoint and EQT (ST:EQTAB).

© Reuters. FILE PHOTO: Overview of Amsterdam's stock exchange interior as Prosus begins trading on the Euronext stock exchange in Amsterdam, Netherlands, September 11, 2019. REUTERS/Piroschka van de Wouw/File Photo

Stockholm-listed EQT has seen its share price increase four-fold over five years from its IPO while assets under management also grew.

($1 = 0.9316 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.